On April 10, 2017, Alterola Biotech, Inc. appointed Mr. Freitag as new Director, President, CEO, Secretary and Treasurer. Following this appointment, the board accepted the resignation of Mr. Lauritsen as former sole officer and director. From February 2016 to the present Mr. Freitag has been a Process Specialist on at MSAT, Ballerup, Denmark.

From August 2015 to February 2016, he was Process Technology Consultant at NNE Pharmaplan, Gentofte, Denmark. From Sept 2013 to August 2015, he was Process Specialist/Global Technology Optimization at Xellia ApS, Copenhagen, Denmark. From April 2013 to Sept 2013, he was Large Scale Mfg Associate III, at Biogen Aps, Hiller d, Denmark.